T-Mobile US Inc. (0R2L)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 148.85 |
|---|---|
| 52-week range | 148.16 – 237.04 |
| Return, 1 month / 3 months | −10.5% / −14.9% |
| Return, 1 year / 3 years | −30.8% / +13.1% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 34.8% |
| Worst drawdown (1 year) | -33.9% |
| Average daily value traded | 3.61M USD |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
T-Mobile US is a wireless telecommunications carrier that serves customers across the United States. It provides mobile voice, messaging and data services to individual consumers, families and business customers, along with mobile devices and related equipment. The company also offers home broadband and other connected services built on its wireless network. It is headquartered in Bellevue, Washington, and operates as the American wireless business of Deutsche Telekom.
T-Mobile US Inc. trades under the code 0R2L on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
T-Mobile US Inc. (0R2L) trades on the London Exchange in UK. It last closed at USD 148.85 on 23 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 2,914 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.8% and over the last three months it fell 14.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.3% | ||
| From 52-week high | -32.9% | ||
| Momentum | 18 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.9% | ||
| 6-month return | -22.5% | ||
| 12-month return, skipping the last month | -22.7% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.9% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.61M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.3% |
|---|---|
| 1 month | −10.5% |
| 3 months | −14.9% |
| 6 months | −22.5% |
| 1 year | −30.8% |
| 3 years | +13.1% |
| 5 years | +34.3% |
Signals
| 50-day / 200-day average | 170.51 / 186.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Aug 2026 | USD 1.0200 |
| 28 May 2026 | USD 1.0200 |
| 26 Feb 2026 | USD 1.0200 |
| 25 Nov 2025 | USD 1.0200 |
| 28 Aug 2025 | USD 0.8800 |
| 29 May 2025 | USD 0.8800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.